Filing Details
- Accession Number:
- 0001127602-15-002025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-16 17:49:18
- Reporting Period:
- 2015-01-15
- Filing Date:
- 2015-01-16
- Accepted Time:
- 2015-01-16 17:49:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376548 | Elliot Ehrich | 852 Winter St. Waltham MA 02451 | Svp, R&D & Cmo, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2015-01-15 | 375 | $18.60 | 23,348 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2015-01-15 | 18,000 | $18.11 | 41,348 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2015-01-15 | 11,200 | $66.06 | 30,148 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-01-15 | 6,400 | $66.96 | 23,748 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-01-15 | 775 | $68.02 | 22,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2015-01-15 | 375 | $0.00 | 375 | $18.60 |
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2015-01-15 | 18,000 | $0.00 | 18,000 | $18.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-12-09 | No | 4 | M | Direct | |
| 82,000 | 2012-05-20 | 2021-05-20 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.62 to $66.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.62 to $67.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.68 to $68.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These options are fully vested in accordance with their terms.
- Shares subject to the stock option award vest in four equal annual installments commencing on 5/20/12.
Billionaire Hedge Funds
